Patient data can predict life expectancy for older adults with diabetes

June 19, 2020

A new study finds that clinicians can use patient data, such as a history of co-occurring health conditions and medication, to predict the 5- and 10-year life expectancy of older people with diabetes.

The ability to make such predictions, the researchers say, may help clinicians and patients develop personalized treatment goals that balance risks and benefits.

The results appear June 19 in the journal Diabetes Care.

Drs. Kevin Griffith and Paul Conlin of the VA Boston Healthcare System led the study.

The researchers embarked on the study knowing that federal and professional society clinical practice guidelines recommend that treatment goals be individualized for older adults with diabetes.

Key factors that impact diabetes treatment goals include co-occurring health conditions (such as severe mental illness or cancer); diabetes complications, such as chronic kidney disease and heart failure; co-existing conditions, and life expectancy.

The benefits of lower blood sugar can take several years to occur. For some older adults with limited life expectancy, the treatment burden may not be worth the benefits.

"But the guidelines don't give doctors guidance for how to decide whether or not people fall into these different bins for life expectancy," Griffith noted. "Furthermore, clinicians are notoriously inaccurate in predicting life expectancy, with studies frequently showing both over- and underestimating. We developed models with high predictive validity of future mortality in a large sample of older Veterans with diabetes."

Conlin added: "Our goal was to use the best available information to inform decision-making in setting glucose control targets. Doctors and patients, of course, can then use their own judgment to make a decision."

The researchers reviewed the electronic health record data of more than 275,000 Veterans with diabetes who were at least 65 years old.

Using predictive modeling techniques, they identified 37 predictive factors that have previously been linked to, or are suspected to impact, mortality in older adults with diabetes: demographic variables (age, sex, marital status); prescriptions for insulin or sulfonylureas, a class of diabetes drugs; and biomarkers such as hemoglobin A1c, blood pressure, body mass index, and levels of cholesterol and triglycerides, a type of fat found in the blood.

The 37 predictive factors also included inpatient and outpatient history and more than 20 medical procedures and co-occurring health disorders.

The results placed patients in three time frames for expected death: within five years, 5 to 10 years, and more than 10 years.

The final predictive models for 5- and 10-year mortality had high predictive validity and demonstrate the importance of several individual and condition-specific characteristics that may inform clinicians and patients about life expectancy.

"We aren't saying, for example, that any of these risk factors result in decreased life expectancy," Griffith commented. "However, the more risk factors that individuals have, the greater the risk of higher mortality over time."

The researchers suggested that these results could assist clinicians in using shared decision-making to establish A1c target ranges that balance treatment benefits and risks.

The study has some important limitations. Since the analysis was based on a Veteran cohort and on older adults, it is possible that results may not generalize to other settings. However, the predictive models can be evaluated by other health care systems that have similar electronic health care records.

It is also possible that recent changes in the approach to older adults with diabetes, such as less emphasis on tight blood sugar control, as well as treatment advances especially for congestive heart failure and chronic kidney disease, could affect model results.

Conlin said he hopes that in the future, predictive models will come into use at the point of care to help clinicians and patients mutually set diabetes treatment goals. However, he noted that the study findings are immediately relevant to clinicians.

"Our results identify multiple common conditions that can easily be identified in clinical practice and assist clinicians in shared decision-making with patients, which is a key recommendation of the VA/DoD Diabetes Guidelines," said Conlin.

On a related note, VA recently launched an Understand Your Diabetes Numbers campaign to assist patients with treatment decisions.
-end-


Veterans Affairs Research Communications

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.